BAG6 and cancer: Bag6-deficient tumors grew much faster compared to Bag6-expressing tumors and were characterized by decreased T cell infiltration and accumulation of inflammatory cancer-associated fibroblasts (iCAFs) indicative of a tumor-promoting TME.